Hims & Hers Health, Inc.HIMSEarnings & Financial Report
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
HIMS Q1 FY2026 Key Financial Metrics
Revenue
$608.1M
Gross Profit
$396.8M
Operating Profit
$133.0M
Net Profit
N/A
Gross Margin
65.2%
Operating Margin
21.9%
Net Margin
N/A
YoY Growth
3.8%
EPS
$-0.40
Hims & Hers Health, Inc. Q1 FY2026 Financial Summary
Hims & Hers Health, Inc. reported revenue of $608.1M (up 3.8% YoY) for Q1 FY2026, with a net profit of N/A (N/A margin). Cost of goods sold was $211.3M, operating expenses totaled $263.8M.
Key Financial Metrics
| Total Revenue | $608.1M |
|---|---|
| Net Profit | N/A |
| Gross Margin | 65.2% |
| Operating Margin | 21.9% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Hims & Hers Health, Inc. Q1 FY2026 revenue of $608.1M breaks down across 2 segments, led by United States Revenue at $529.9M (87.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| United States Revenue | $529.9M | 87.1% |
| Rest of the World Revenue | $78.2M | 12.9% |
Hims & Hers Health, Inc. Annual Revenue by Year
Hims & Hers Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.3B).
Hims & Hers Health, Inc. Quarterly Revenue & Net Profit History
Hims & Hers Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $608.1M | +3.8% | N/A | N/A |
| Q4 FY2025 | $617.8M | +28.4% | $20.6M | 3.3% |
| Q3 FY2025 | $599.0M | +49.2% | $15.8M | 2.6% |
| Q2 FY2025 | $544.8M | +72.6% | $42.5M | 7.8% |
| Q1 FY2025 | $586.0M | +110.7% | $49.5M | 8.4% |
| Q4 FY2024 | $481.1M | +95.1% | $26.0M | 5.4% |
| Q3 FY2024 | $401.6M | +77.1% | $75.6M | 18.8% |
| Q2 FY2024 | $315.6M | +51.8% | $13.3M | 4.2% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $315.6M | $401.6M | $481.1M | $586.0M | $544.8M | $599.0M | $617.8M | $608.1M |
| YoY Growth | 51.8% | 77.1% | 95.1% | 110.7% | 72.6% | 49.2% | 28.4% | 3.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $480.5M | $602.3M | $707.5M | $891.7M | $1.88B | $2.23B | $2.15B | $2.27B |
| Liabilities | $118.5M | $162.2M | $230.8M | $342.4M | $1.31B | $1.65B | $1.61B | $1.82B |
| Equity | $362.0M | $440.1M | $476.7M | $549.3M | $562.7M | $581.0M | $540.9M | $446.2M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $53.6M | $85.3M | $86.4M | $109.1M | $-19.1M | $148.7M | $61.3M | $89.4M |